9 results  1 of 1 

1 EGFR and HER2 Expression in Papillary Thyroid Carcinoma
Yong-Seon Kim, Jeong-Soo Kim, Yong-Seok Kim
J Endocr Surg.2018;18(4):228-235.   Published online 2018 December 26     DOI: http://dx.doi.org/10.16956/jes.2018.18.4.228
      
2 Clinical Differences in Triple-Positive Operable Breast Cancer Subtypes in Korean Patients: An Analysis of Korean Breast Cancer Registry Data
Sun Hyong You, Byung Joo Chae, Yong Hwa Eom, Tae-Kyung Yoo, Yong-seok Kim, Jeong Soo Kim, Woo-Chan Park
J Breast Cancer.2018;21(4):415-424.   Published online 2018 November 23     DOI: http://dx.doi.org/10.4048/jbc.2018.21.e53
      
3 PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis
Youjeong Seo, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im, Seok Jin Nam, Soo Youn Cho, Eun Yoon Cho
J Breast Cancer.2018;21(4):382-390.   Published online 2018 October 29     DOI: http://dx.doi.org/10.4048/jbc.2018.21.e48
      
4 FcrR3A-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based Treatment
Heejung Chae, Changhoon Yoo, Jung-A Yoon, Hee Jin Lee, Kyu-pyo Kim, Jeong-Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Gyungyub Gong, Sung-Bae Kim
J Breast Cancer.2018;21(1):45-50.   Published online 2018 March 23     DOI: http://dx.doi.org/10.4048/jbc.2018.21.1.45
      
5 FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation
Jinju Park, Yiseul Choi, Young San Ko, Younghoon Kim, Jung-Soo Pyo, Bo Gun Jang, Min A Kim, Jae-Seon Lee, Mee Soo Chang, Jong-Wan Park, Byung Lan Lee
Cancer Res Treat.2018;50(1):239-254.   Published online 2017 March 24     DOI: http://dx.doi.org/10.4143/crt.2016.580
      
6 A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
Jun Ho Yi, Jung Hun Kang, In Gyu Hwang, Hee Kyung Ahn, Hyun Jin Baek, Soon Il Lee, Do Hyoung Lim, Young-Woong Won, Jun Ho Ji, Hyo Song Kim, Sun Young Rha, Sung Yong Oh, Kyung Eun Lee, Taekyu Lim, Chi Hoon Maeng, Moon Jin Kim, Seung Tae Kim, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Se Hoon Park
Cancer Res Treat.2016;48(2):553-560.   Published online 2015 August 10     DOI: http://dx.doi.org/10.4143/crt.2015.155
      
7 Patterns of Recurrence after Breast-Conserving Treatment for Early Stage Breast Cancer by Molecular Subtype
Jae Myoung Noh, Doo Ho Choi, Seung Jae Huh, Won Park, Jung Hyun Yang, Seok Jin Nam, Young Hyuck Im, Jin Seok Ahn
J Breast Cancer.2011;14(1):46-51.   Published online 2011 March 31     DOI: http://dx.doi.org/10.4048/jbc.2011.14.1.46
      
8 Branched-chain Assay for ER, PR, and HER2 RNA Levels is a Useful Adjunct in the Evaluation of ER, PR, and HER2 in Breast Cancer
Hyeon Woo Yim, Byung Joo Song, Sang Seol Jung, Hyun-Joo Kim, Yeong-Jin Choi, Kyo-Young Lee, Ahwon Lee
J Breast Cancer.2010;13(3):267-274.   Published online 2010 September 29     DOI: http://dx.doi.org/10.4048/jbc.2010.13.3.267
      
9 Comparison of Silver-Enhanced in situ Hybridization and Fluorescence in situ Hybridization for HER2 Gene Status in Breast Carcinomas
Jun Kang, Gui Young Kwon, Young-Hee Lee, Gyungyub Gong
J Breast Cancer.2009;12(4):235-240.   Published online 2009 December 31     DOI: http://dx.doi.org/10.4048/jbc.2009.12.4.235
      

 1 of 1